The Use of Virtual Reality Applications in Tension-Type Headaches

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

140 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-12-15

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary aim of this research is to objectively assess the impact of virtual reality (VR) technology on pain symptoms in tension-type headache patients. This study is designed to understand the potential of VR in the treatment of tension-type headaches, exploring its ability to reduce pain severity and improve patients' quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Additional Benefits of Virtual Reality Therapy for Individuals With Neck Pain

NCT06235515

Neck Pain Virtual Reality Rehabilitation

COMPLETED NA

Effects of Virtual Reality on Brain Hemodynamic Activity in Chronic Pain

NCT06154850

Chronic Pain Rheumatoid Arthritis Virtual Reality

COMPLETED NA

Virtual Reality in Chronic Neck Pain

NCT06549166

Neck Pain

NOT_YET_RECRUITING NA

Virtual Reality Program for Managing Chronic Neck Pain

NCT07189052

Chronic Neck Pain

NOT_YET_RECRUITING NA

Motion Sickness Rehabilitation for Virtual Reality

NCT06056622

Motion Sickness

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Tension-type headache is a prevalent health issue that can cause significant discomfort to patients. The potential use of VR goggles as an effective alternative treatment option in these patients is crucial in clinical applications. The quality of life of tension-type headache patients is often affected. If VR goggle technology can enhance the quality of life for these patients, it would be a significant finding.

Additionally, our research may contribute more data to the scientific literature on the impact of VR goggle technology in headache treatment. This could assist future researchers in designing similar studies and better understanding the results. If VR goggle technology proves effective, it could contribute to diversifying treatment options for tension-type headache patients and improving access to treatment.

The primary objective of the study is to investigate the effect of virtual reality therapy on pain symptoms in tension-type headache patients. If the results are positive, VR technologies may alleviate pain and enhance the quality of life for these patients. It could also help them function better in their daily lives. If relaxation is found to be effective in the VR group, a new treatment option would be introduced for tension-type headache patients. This could contribute to the diversification of treatment options.

The study poses no risk to the patient. The patient will lie on the bed, and the VR goggles will be used accordingly.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Headache Analgesia Tension-Type Headache

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standart Group

Participants will be selected from patients diagnosed with tension-type headache according to the International Classification of Headache Disorders, third edition (ICHD-3) criteria. All selected participants will be administered 25 mg of dexketoprofen.

Group Type NO_INTERVENTION

No interventions assigned to this group

Virtual Reality

Participants will be selected from patients diagnosed with tension-type headache according to the International Classification of Headache Disorders, third edition (ICHD-3) criteria. Selected participants, in addition to being administered 25 mg of dexketoprofen, will also use virtual reality goggles.

Group Type EXPERIMENTAL

Virtual Reality

Intervention Type DEVICE

Participants will be selected from patients diagnosed with tension-type headache according to the International Classification of Headache Disorders, third edition (ICHD-3) criteria. Selected participants, in addition to being administered 25 mg of dexketoprofen, will also use virtual reality goggles.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual Reality

Participants will be selected from patients diagnosed with tension-type headache according to the International Classification of Headache Disorders, third edition (ICHD-3) criteria. Selected participants, in addition to being administered 25 mg of dexketoprofen, will also use virtual reality goggles.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients between the ages of 18 and 65
* Patients meeting the criteria for Tension-Type Headache (TTH) in the third edition of the International Classification of Headache Disorders
* Patients willing to participate in the study
* Patients indicating a VAS score of 50 and above
* Patients without other suspected diagnoses
* Patients with no known history of adverse reactions to the active ingredients of the drugs to be used
* Conscious patients
* Patients who are oriented and cooperative

Exclusion Criteria

* Patients under the age of 18 and over the age of 65
* Patients who do not consent to participate in the study
* Patients with vital signs outside normal limits
* Patients with a history of adverse reactions to known NSAIDs
* Individuals unable to determine pain intensity on the VAS
* Patients with a VAS score of 50 mm and below
* Pregnant individuals
* Those with advanced systemic diseases
* Patients with malignancies
* Individuals with chronic liver and kidney diseases
* Those using sedative and analgesic neuro-psychiatric drugs
* Individuals with a history of psychological and neurological diseases
* Patients who used analgesics within 8 hours before the examination

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No